Literature DB >> 24793844

Animal models of Alzheimer disease: historical pitfalls and a path forward.

Sarah E Cavanaugh1, John J Pippin, Neal D Barnard.   

Abstract

Alzheimer disease (AD) is a medically and financially overwhelming condition, and incidence rates are expected to triple by 2050.Despite decades of research in animal models of AD, the disease remains incompletely understood, with few treatment options. This review summarizes historical and current AD research efforts, with emphasis on the disparity between preclinical animal studies and the reality of human disease and how this has impacted clinical trials. Ultimately, we provide a mechanism for shifting the focus of AD research away from animal models to focus primarily on human biology as a means to improve the applicability of research findings to human disease. Implementation of these alternatives may hasten development of improved strategies to prevent, detect, ameliorate, and possibly cure this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793844     DOI: 10.14573/altex.1310071

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  41 in total

Review 1.  Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans: Genomic Prediction.

Authors:  Naomi R Wray; Kathryn E Kemper; Benjamin J Hayes; Michael E Goddard; Peter M Visscher
Journal:  Genetics       Date:  2019-04       Impact factor: 4.562

Review 2.  Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".

Authors:  Madhav Thambisetty
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-14       Impact factor: 4.249

3.  Gestational Stress Augments Postpartum β-Amyloid Pathology and Cognitive Decline in a Mouse Model of Alzheimer's Disease.

Authors:  Zahra Jafari; Jogender Mehla; Bryan E Kolb; Majid H Mohajerani
Journal:  Cereb Cortex       Date:  2019-08-14       Impact factor: 5.357

Review 4.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

5.  Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ1-42 and Decreased Synaptic Marker PSD-95 in Zebrafish Larvae.

Authors:  Laura Roesler Nery; Natalia Eltz Silva; Raphaela Fonseca; Monica Ryff Moreira Vianna
Journal:  Neurochem Res       Date:  2017-06-16       Impact factor: 3.996

6.  TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.

Authors:  Yingjun Zhao; Xilin Wu; Xiaoguang Li; Lu-Lin Jiang; Xun Gui; Yan Liu; Yu Sun; Bing Zhu; Juan C Piña-Crespo; Muxian Zhang; Ningyan Zhang; Xiaochun Chen; Guojun Bu; Zhiqiang An; Timothy Y Huang; Huaxi Xu
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

7.  Optimised PDMS Tunnel Devices on MEAs Increase the Probability of Detecting Electrical Activity from Human Stem Cell-Derived Neuronal Networks.

Authors:  Maria Toivanen; Anssi Pelkonen; Meeri Mäkinen; Laura Ylä-Outinen; Lassi Sukki; Pasi Kallio; Mervi Ristola; Susanna Narkilahti
Journal:  Front Neurosci       Date:  2017-10-31       Impact factor: 4.677

Review 8.  Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.

Authors:  Boris Decourt; Debomoy K Lahiri; Marwan N Sabbagh
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

9.  Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.

Authors:  Bonnie J Berry; Alec S T Smith; Christopher J Long; Candace C Martin; James J Hickman
Journal:  ACS Chem Neurosci       Date:  2018-05-22       Impact factor: 4.418

10.  Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease.

Authors:  Roy Lardenoije; Daniël L A van den Hove; Monique Havermans; Anne van Casteren; Kevin X Le; Roberta Palmour; Cynthia A Lemere; Bart P F Rutten
Journal:  Mol Cell Neurosci       Date:  2017-11-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.